Newborn Screening by DNA-First: Systematic Evaluation of the Eligibility of Inherited Metabolic Disorders Based on Treatability

Newborn Screening by DNA-First: Systematic Evaluation of the Eligibility of Inherited Metabolic Disorders Based on Treatability

The biomarker-based Dutch Newborn Screening (NBS) panel (as of 2024) comprises 19 inherited metabolic disorders (IMDs). With the use of next-generation sequencing (NGS) as a first-tier screen, NBS could expand to include IMDs that lack a reliable biochemical footprint in dried blood spots, while als...

Full description

Saved in:
Bibliographic Details
Main Authors: Abigail Veldman, Birgit Sikkema-Raddatz, Terry G. J. Derks, Clara D. M. van Karnebeek, M. B. Gea Kiewiet, Margaretha F. Mulder, Marcel R. Nelen, M. Estela Rubio-Gozalbo, Richard J. Sinke, Monique G. de Sain-van der Velden, Gepke Visser, Maaike C. de Vries, Dineke Westra, Monique Williams, Ron A. Wevers, M. Rebecca Heiner-Fokkema, Francjan J. van Spronsen
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:International Journal of Neonatal Screening
Subjects:
inherited metabolic disease
inborn errors of metabolism
newborn screening
treatability
heel prick
Wilson and Jungner criteria
Online Access:https://www.mdpi.com/2409-515X/11/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items